IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE-Reference-Cited by-同舟云学术

IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE

Published:2020-01-30 Issue:2 Volume:5 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Li Dan,Matta Bharati^ORCID,Song Su,Nelson Victoria,Diggins Kirsten,Simpfendorfer Kim R.^ORCID,Gregersen Peter K.^ORCID,Linsley Peter^ORCID,Barnes Betsy J.^ORCID

Funder

Alliance for Lupus Research

NIH NIAMS

FAMRI

Lupus Research Alliance

U.S. Department of Defense

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/124020/files/pdf

Reference88 articles.

1. Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

2. Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides

3. Autoantibodies and SLE—the threshold for disease

4. Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus

5. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IRF5 mediates adaptive immunity via altered glutamine metabolism, mTORC1 signaling and post-transcriptional regulation following T cell receptor activation;2024-08-27

2. Genetic polymorphisms in genes involved in the type I interferon system (STAT4 and IRF5): association with Asian SLE patients;Clinical Rheumatology;2024-07-04

3. Type I interferon pathway in pediatric systemic lupus erythematosus;World Journal of Pediatrics;2024-06-25

4. Immmunometabolism of systemic lupus erythematosus;Clinical Immunology;2024-04

5. Systematic immune cell dysregulation and molecular subtypes revealed by single-cell RNA-seq of subjects with type 1 diabetes;Genome Medicine;2024-03-27